Daljit Singh Aurora sold $270k of NMRA
See Remarks at Neumora Therapeutics, Inc.. 176,060 shares at an average of $1.53, traded Aug 20, 2026, filed Aug 21, 2026.
Score components
- +15RoleOfficer
- +13Trade size$270k at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001610717-26-000385, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | MOption exercise Common Stock | +67,741 | $0.72 | $49k | 116,491 | Aug 21, 2026 |
| Aug 20, 2026 | SOpen-market sale Common Stock | -67,741 | $1.51 | $103k | 48,750 | Aug 21, 2026 |
| Aug 20, 2026 | MOption exercise Common Stockindirect: See footnote | +21,685 | $0.72 | $16k | 21,685 | Aug 21, 2026 |
| Aug 20, 2026 | MOption exercise Common Stockindirect: See footnote | +45,026 | $0.72 | $32k | 66,711 | Aug 21, 2026 |
| Aug 20, 2026 | SOpen-market sale Common Stockindirect: See footnote | -66,711 | $1.51 | $101k | 0 | Aug 21, 2026 |
| Aug 21, 2026 | MOption exercise Common Stock | +20,553 | $0.72 | $15k | 69,303 | Aug 21, 2026 |
| Aug 21, 2026 | SOpen-market sale Common Stock | -20,553 | $1.59 | $33k | 48,750 | Aug 21, 2026 |
| Aug 21, 2026 | MOption exercise Common Stockindirect: See footnote | +21,055 | $0.72 | $15k | 21,055 | Aug 21, 2026 |
| Aug 21, 2026 | SOpen-market sale Common Stockindirect: See footnote | -21,055 | $1.60 | $34k | 0 | Aug 21, 2026 |
| Aug 20, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -67,741 | $0.00 | $0 | 109,527 | Aug 21, 2026 |
| Aug 20, 2026 | MOption exercise Stock Option (Right to Buy)derivativeindirect: See footnote | -45,026 | $0.00 | $0 | 0 | Aug 21, 2026 |
| Aug 20, 2026 | MOption exercise Stock Option (Right to Buy)derivativeindirect: See footnote | -21,685 | $0.00 | $0 | 115,853 | Aug 21, 2026 |
| Aug 20, 2026 | AGrant or award Stock Option (Right to Buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Aug 21, 2026 |
| Aug 21, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -20,553 | $0.00 | $0 | 88,974 | Aug 21, 2026 |
| Aug 21, 2026 | MOption exercise Stock Option (Right to Buy)derivativeindirect: See footnote | -21,055 | $0.00 | $0 | 94,798 | Aug 21, 2026 |
Related signals
Other insiders at Neumora Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 37Weak | NMRAsell Neumora Therapeutics, Inc. | Daljit Singh Aurora See Remarks | $432k 277,773 shares | -198% | |
| 30Weak | Neumora Therapeutics, Inc. | Daljit Singh Aurora See Remarks | $22k 6,165 shares | -7% | |
| 36Weak | Neumora Therapeutics, Inc. | Paul L Berns See Remarks | $34k 9,819 shares | -0% | |
| 10Weak | Neumora Therapeutics, Inc. | Michael Lee Milligan See Remarks | $5,119 1,436 shares | -6% | |
| 35Weak | Neumora Therapeutics, Inc. | Joshua Pinto President | $21k 5,967 shares | -9% | |
| 29Weak | Neumora Therapeutics, Inc. | Daljit Singh Aurora See Remarks | $307k 114,703 shares | -100% | |
| 61Notable | Neumora Therapeutics, Inc. | ARCH Venture Partners X, LLC owner | $5.0M 1,915,700 shares | +46% | |
| 61Notable | Neumora Therapeutics, Inc. | ARCH Venture Partners XII, LLC owner | $5.0M 1,915,700 shares | +46% | |
| 69Notable | Neumora Therapeutics, Inc. | Kristina Burow director, owner | $5.0M 1,915,700 shares | +46% | |
| 3Weak | Neumora Therapeutics, Inc. | Daljit Singh Aurora Chief Strategy Officer | $14k 8,565 shares | -9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.